Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Crystal L Mackall

Showing results (11-20 of 231) with videos related to

Pageof 24
Sort By:
Blood|May 16, 2002
Interleukin-7: from bench to clinicTerry J Fry, Crystal L Mackall
Pediatric Blood & Cancer|May 3, 2007
Therapy for metastatic ESFT: is it time to ask new questions?Kristen M Snyder, Crystal L Mackall
Springer Seminars in Immunopathology|April 27, 2002
Current concepts of thymic agingTerry J Fry, Crystal L Mackall
Critical Reviews in Oncogenesis|September 10, 2015
Emerging Immunotherapies for Cancer and Their Potential for Application in Pediatric OncologyRimas J Orentas, Crystal L Mackall
Blood Advances|January 4, 2018
Immunotherapy for acute lymphoblastic leukemia: from famine to feastKara L Davis, Crystal L Mackall
Cancer Discovery|August 24, 2018
Tumor Antigen Escape from CAR T-cell TherapyRobbie G Majzner, Crystal L Mackall
The Oncologist|November 10, 2009
Current approach to pediatric soft tissue sarcomasMelinda S Merchant, Crystal L Mackall
Nature Reviews. Immunology|January 12, 2019
CAR T cell therapy: inroads to response and resistanceChristine E Brown, Crystal L Mackall
Cancer Chemotherapy and Biological Response Modifiers|August 23, 2005
Cancer therapy-induced immune modulationJessica C Karl, Crystal L Mackall
Cancer Journal (Sudbury, Mass.)|August 10, 2010
Novel gamma-chain cytokines as candidate immune modulators in immune therapies for cancerNatasha M Fewkes, Crystal L Mackall
Pageof 24

Showing results (11-20 of 231) with videos related to

Sort By:
Pageof 24
Blood|May 16, 2002
Interleukin-7: from bench to clinicTerry J Fry, Crystal L Mackall
Pediatric Blood & Cancer|May 3, 2007
Therapy for metastatic ESFT: is it time to ask new questions?Kristen M Snyder, Crystal L Mackall
Springer Seminars in Immunopathology|April 27, 2002
Current concepts of thymic agingTerry J Fry, Crystal L Mackall
Critical Reviews in Oncogenesis|September 10, 2015
Emerging Immunotherapies for Cancer and Their Potential for Application in Pediatric OncologyRimas J Orentas, Crystal L Mackall
Blood Advances|January 4, 2018
Immunotherapy for acute lymphoblastic leukemia: from famine to feastKara L Davis, Crystal L Mackall
Cancer Discovery|August 24, 2018
Tumor Antigen Escape from CAR T-cell TherapyRobbie G Majzner, Crystal L Mackall
The Oncologist|November 10, 2009
Current approach to pediatric soft tissue sarcomasMelinda S Merchant, Crystal L Mackall
Nature Reviews. Immunology|January 12, 2019
CAR T cell therapy: inroads to response and resistanceChristine E Brown, Crystal L Mackall
Cancer Chemotherapy and Biological Response Modifiers|August 23, 2005
Cancer therapy-induced immune modulationJessica C Karl, Crystal L Mackall
Cancer Journal (Sudbury, Mass.)|August 10, 2010
Novel gamma-chain cytokines as candidate immune modulators in immune therapies for cancerNatasha M Fewkes, Crystal L Mackall
Pageof 24